- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET) in Australia
Total 333 results
-
Provectus PharmaceuticalsCompleted
-
Karsten GavenisRecruitingNeuroendocrine Tumors | Neuroendocrine CarcinomaGermany, Austria
-
Medical University of ViennaCompleted
-
CytomX TherapeuticsTerminatedSolid Tumor | Unresectable or Metastatic MelanomaKorea, Republic of, United States, Netherlands, Spain, Australia
-
InxMed (Shanghai) Co., Ltd.RecruitingMetastatic MelanomaUnited States, Australia
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMelanoma | MetastasisAustralia
-
Melanoma and Skin Cancer Trials LimitedMelanoma Institute AustraliaCompleted
-
University of SydneyMelanoma and Skin Cancer Trials LimitedCompleted
-
Eli Lilly and CompanyCompletedMetastatic MelanomaAustralia, United States
-
University Hospital, ToursEuropean Academy of Dermatology and VenerologyNot yet recruitingMerkel Cell CarcinomaUnited Kingdom, Austria, Finland, France, Germany, Italy, Netherlands, Romania, Sweden, Turkey
-
Medical University of GrazCompletedMelanoma | Skin Cancer | Merkel Cell Carcinoma | Basal Cell Carcinoma | Squamous Cell CarcinomaAustria
-
Medical University of ViennaUnknown
-
Melanoma Institute AustraliaActive, not recruiting
-
Novartis PharmaceuticalsCompletedPancreatic Neoplasms | Neuroendocrine Tumor | Neuroendocrine Carcinoma | Islet Cell CarcinomaUnited States, Canada, Spain, Argentina, Germany, Belgium, Italy, France, Sweden, Australia, Netherlands
-
Melanoma and Skin Cancer Trials LimitedMonash UniversityCompletedSkin Cancer | Melanoma (Skin)Australia
-
Ludwig Institute for Cancer ResearchInstitute of Cancer Research, United KingdomCompletedMelanomaUnited Kingdom, Australia, New Zealand
-
Melanoma Institute AustraliaBristol-Myers SquibbRecruitingMelanoma Stage IvAustralia, Norway
-
Melanoma and Skin Cancer Trials LimitedBristol-Myers Squibb; Amgen; Peter MacCallum Cancer Centre, AustraliaActive, not recruitingMelanoma | Melanoma Stage Iv | Melanoma Stage IiiAustralia
-
GlaxoSmithKlineCompleted
-
Medical University of ViennaTerminated
-
Novo Nordisk A/SCompleted
-
Medical University of ViennaRecruitingUveal MelanomaAustria
-
ViralyticsCompletedStage IV MelanomaAustralia
-
ImmVira Pharma Co. LtdRecruitingMelanoma | Sarcoma | NSCLC | Solid Tumor | HNSCC | Squamous Cell CarcinomaUnited States, Australia
-
Eucure (Beijing) Biopharma Co., LtdActive, not recruitingMelanoma | Pancreatic Ductal AdenocarcinomaUnited States, Australia
-
Merck Sharp & Dohme LLCCompletedMerkel Cell CarcinomaUnited States, Australia, Canada, France, Italy, New Zealand, Spain, Sweden
-
Melanoma and Skin Cancer Trials LimitedTrans Tasman Radiation Oncology GroupActive, not recruiting
-
Medical University of GrazCompleted
-
Ludwig Institute for Cancer ResearchCancer Research Institute, NY, USATerminatedNY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic MelanomaUnresectable or Metastatic MelanomaUnited States, Australia
-
ITM Solucin GmbHABX CRO; PSI CROActive, not recruitingNeuroendocrine TumorsGermany, France, United States, United Kingdom, Australia, Italy, Belgium, Switzerland, Czechia, Spain, Austria, Netherlands, Poland, South Africa
-
Melanoma and Skin Cancer Trials LimitedMelanoma Institute Australia; Cancer Council New South WalesActive, not recruitingMetastatic Melanoma to the Groin Lymph NodesUnited Kingdom, Slovenia, Australia, Brazil, Netherlands, Italy
-
EMD Serono Research & Development Institute, Inc.CompletedCarcinoma, Merkel CellUnited States, Spain, Australia, Italy, Germany, France, Japan
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingMedulloblastoma | Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor | Anaplastic Medulloblastoma | Supratentorial Embryonal Tumor, Not Otherwise SpecifiedUnited States, Canada, Australia, Puerto Rico
-
ActelionCompleted
-
BioNTech RNA Pharmaceuticals GmbHCompleted
-
Merck Sharp & Dohme LLCCompletedMelanomaAustralia, South Africa, Spain, Sweden
-
Medical University of ViennaCompletedStage IV Melanoma | Stage III MelanomaAustria
-
Array BioPharmaTerminatedLocally Advanced Metastatic BRAF Mutant MelanomaAustralia, Canada, Netherlands, United States
-
Piramal Enterprises LimitedCompletedMelanomaAustralia, India, New Zealand
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia
-
BioNTech RNA Pharmaceuticals GmbHCompleted
-
ViralyticsCompletedMalignant MelanomaAustralia
-
Kartos Therapeutics, Inc.RecruitingMerkel Cell CarcinomaUnited States, Netherlands, Korea, Republic of, France, Germany, Spain, Canada, Italy, Australia, Brazil
-
Trans Tasman Radiation Oncology GroupUniversity Medical Center Groningen; Australian and New Zealand Intensive Care...CompletedLymph Node Disease | Malignant MelanomaAustralia, New Zealand, Netherlands, Brazil
-
CelgeneICON Clinical ResearchCompletedMelanoma | Neoplasm MetastasisAustralia, United Kingdom, Ukraine, Germany, Estonia, Latvia, Lithuania, Netherlands, South Africa
-
Novartis PharmaceuticalsTerminatedIslet Cell TumorFrance, Spain, United Kingdom, Belgium, Hungary, Turkey, Canada, Argentina, Sweden, Italy, Thailand, Germany, Netherlands, Brazil, Australia, Japan, United States, Denmark, New Zealand
-
IpsenTerminatedNeuroendocrine Tumors in LungCanada, United States, Germany, France, United Kingdom, Netherlands, Spain, Denmark, Italy, Austria, Poland
-
TakedaCompletedMelanoma | NeoplasmsUnited States, Australia
-
GlaxoSmithKlineCompletedMelanomaAustralia, United States
-
Philogen S.p.A.CompletedMalignant MelanomaAustria, Germany